AKBA NASDAQ
Akebia Therapeutics, Inc.
1W: -9.7%
1M: -28.2%
3M: -13.6%
YTD: -34.2%
1Y: -65.1%
3Y: -2.9%
5Y: -70.4%
$1.02
+0.00 (+0.00%)
Weekly Expected Move ±11.9%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$232M
Revenue
+25.7% YoY
$-21M
Net Income
+54.7% YoY
$60M
Free Cash Flow
+272.1% YoY
76.4%
Gross Margin
-8.8%
Op. Margin
-16.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE247.5%
ROA-6.9%
ROIC6.5%
Valuation
P/E-13.3
P/B10.0
EV/EBITDA127.3
Leverage
Debt/Equity6.63
Current Ratio1.13
Interest Cov.0.2x
Quality Scores
Piotroski F4/9
Altman Z-4.91
Beneish M-2.89